These findings suggest that thrombocytopenia in P. vivax malaria may result from autoantibodies targeting phosphatidylserine on activated platelets, driven by a pro-inflammatory cytokine imbalance, with TGF-β1 potentially exerting a protective effect. Here, TGFB1 is linked to Thrombocytopenia.